News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,489 Results
Type
Article (4465)
Company Profile (15)
Press Release (62009)
Multimedia
Podcasts (5)
Webinars (2)
Section
Business (19563)
Career Advice (125)
Deals (2321)
Drug Delivery (6)
Drug Development (7112)
Employer Resources (3)
FDA (1266)
Job Trends (1150)
News (30048)
Policy (2110)
Tag
Academia (493)
Academic (1)
Accelerated approval (7)
Allergies (12)
Alliances (6746)
ALS (18)
Alzheimer's disease (236)
Antibody-drug conjugate (ADC) (54)
Approvals (1296)
Artificial intelligence (119)
Autoimmune disease (25)
Automation (11)
Bankruptcy (17)
Best Places to Work (973)
BIOSECURE Act (1)
Biosimilars (3)
Biotechnology (11)
Bladder cancer (25)
Brain cancer (20)
Breast cancer (125)
Cancer (1074)
Cardiovascular disease (23)
Career advice (112)
Career pathing (4)
CAR-T (24)
CDC (2)
Cell therapy (52)
Cervical cancer (2)
Clinical research (5403)
Collaboration (306)
Compensation (26)
Complete response letters (3)
COVID-19 (383)
CRISPR (20)
C-suite (115)
Cystic fibrosis (19)
Data (972)
Denatured (1)
Depression (8)
Dermatology (2)
Diabetes (22)
Diagnostics (2854)
Digital health (4)
Diversity (2)
Drug discovery (68)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (16)
Earnings (5217)
Editorial (1)
Employer branding (1)
Employer resources (2)
Events (9129)
Executive appointments (119)
FDA (1524)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (168)
Gene editing (35)
Generative AI (10)
Gene therapy (51)
GLP-1 (61)
Government (415)
Guidances (33)
Healthcare (1684)
HIV (4)
Huntington's disease (1)
IgA nephropathy (5)
Immunology and inflammation (19)
Immuno-oncology (8)
Indications (17)
Infectious disease (429)
Inflammatory bowel disease (22)
Influenza (25)
Intellectual property (24)
Interviews (11)
IPO (923)
IRA (1)
Job creations (204)
Job search strategy (101)
JPM (3)
Kidney cancer (3)
Labor market (1)
Layoffs (19)
Leadership (2)
Legal (248)
Liver cancer (10)
Longevity (5)
Lung cancer (158)
Lymphoma (64)
Machine learning (11)
Management (1)
Manufacturing (39)
MASH (10)
Medical device (509)
Medtech (511)
Mergers & acquisitions (1481)
Metabolic disorders (66)
mRNA (13)
Multiple sclerosis (6)
Neurodegenerative disease (49)
Neuropsychiatric disorders (3)
Neuroscience (345)
NextGen: Class of 2026 (395)
Non-profit (417)
Now hiring (10)
Obesity (34)
Opinion (22)
Ovarian cancer (15)
Pain (15)
Pancreatic cancer (51)
Parkinson's disease (26)
Partnered (3)
Patents (39)
Patient recruitment (45)
Peanut (4)
People (7405)
Pharmaceutical (1)
Phase 1 (2276)
Phase 2 (2488)
Phase 3 (1458)
Pipeline (767)
Policy (5)
Postmarket research (107)
Preclinical (1704)
Press Release (18)
Prostate cancer (52)
Psychedelics (3)
Radiopharmaceuticals (60)
Rare diseases (67)
Real estate (455)
Recruiting (1)
Regulatory (1827)
Reports (7)
Research institute (617)
Resumes & cover letters (15)
Rett syndrome (3)
RNA editing (3)
RSV (4)
Schizophrenia (5)
Series A (27)
Series B (11)
Sickle cell disease (3)
Spinal muscular atrophy (21)
Sponsored (3)
Startups (461)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
The Weekly (4)
Vaccines (45)
Venture capital (4)
Weight loss (15)
Women's health (5)
Worklife (1)
Date
Last 7 days (55)
Last 30 days (267)
Last 365 days (2963)
2026 (783)
2025 (3018)
2024 (3421)
2023 (4197)
2022 (5476)
2021 (5637)
2020 (5209)
2019 (3593)
2018 (2708)
2017 (3406)
2016 (3407)
2015 (3996)
2014 (2757)
2013 (2314)
2012 (2478)
2011 (2650)
2010 (2205)
Location
Africa (61)
Alabama (3)
Alaska (1)
Arizona (22)
Asia (3484)
Australia (728)
California (1222)
Canada (278)
China (165)
Colorado (34)
Connecticut (55)
Delaware (56)
Europe (10145)
Florida (139)
Georgia (9)
Idaho (3)
Illinois (103)
India (9)
Indiana (46)
Iowa (2)
Japan (58)
Kansas (6)
Kentucky (2)
Louisiana (1)
Maine (3)
Maryland (123)
Massachusetts (872)
Michigan (22)
Minnesota (52)
Missouri (17)
Montana (2)
Nevada (1)
New Hampshire (2)
New Jersey (207)
New Mexico (7)
New York (379)
North Carolina (94)
North Dakota (4)
Northern California (642)
Ohio (39)
Oklahoma (1)
Oregon (4)
Pennsylvania (178)
Rhode Island (4)
South America (76)
South Carolina (1)
Southern California (419)
Tennessee (21)
Texas (309)
United States (4167)
Utah (132)
Virginia (18)
Washington D.C. (6)
Washington State (109)
Wisconsin (36)
66,489 Results for "diasorin molecular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbix Presents Molecular Pathology Platform Results
February 4, 2026
·
5 min read
Press Releases
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
March 26, 2026
·
6 min read
Press Releases
Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio
February 24, 2026
·
2 min read
Press Releases
Axonia Medical Acquires 51% Stake in Dipylon Medical in Strategic Move to Scale Global Molecular Diagnostics Platform
March 26, 2026
·
2 min read
Press Releases
KIFFIK Biomedical and HekaBio Announce Strategic Alliance to Expand ISF-Based Molecular Access Across Asia-Pacific
March 24, 2026
·
3 min read
Press Releases
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
March 3, 2026
·
7 min read
Press Releases
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
March 18, 2026
·
4 min read
Press Releases
Devonian reports additional molecular data from MASH liver study
February 12, 2026
·
9 min read
Press Releases
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease
March 17, 2026
·
7 min read
Collaboration
Novartis Sticks With Monte Rosa in Second Molecular Glue Deal Worth up to $5.7B
Novartis and Monte Rosa first partnered in October 2024 for a molecular glue asset for immune-mediated and autoimmune diseases. This time, the pharma is putting $120 million down upfront for more of the biotech’s AI-discovered degraders.
September 15, 2025
·
2 min read
·
Tristan Manalac
1 of 6,649
Next
